68 related articles for article (PubMed ID: 30429016)
1. Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients.
Frost N; Tessmer A; Schmittel A; van Laak V; Raspe M; Ruwwe-Glösenkamp C; Brunn M; Senger C; Böhmer D; Ochsenreither S; Temmesfeld-Wollbrück B; Furth C; Schmidt B; Neudecker J; Rückert JC; Suttorp N; Witzenrath M; Grohé C
Lung Cancer; 2018 Nov; 125():164-173. PubMed ID: 30429016
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience.
Mohamed AA; Goncalves M; Singh BP; Tometten M; Rashad A; Hölzle F; Hackenberg S; Eble M
Strahlenther Onkol; 2024 May; 200(5):400-408. PubMed ID: 38063900
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease.
Guberina M; Pöttgen C; Guberina N; Hoffmann C; Wiesweg M; Richlitzki C; Metzenmacher M; Aigner C; Bölükbas S; Gauler T; Eberhardt WEE; Forsting M; Herrmann K; Theegarten D; Darwiche K; Jendrossek V; Stuschke M; Schuler M
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539510
[No Abstract] [Full Text] [Related]
4. Multimodal treatment of oligometastatic non-small cell lung cancer.
Graça LL; Pego A; Lareiro S; Pancas R
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38061851
[TBL] [Abstract][Full Text] [Related]
5. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Kroese TE; Bronzwaer S; van Rossum PSN; Schoppman SF; Deseyne PRAJ; van Cutsem E; Haustermans K; Nafteux P; Thomas M; Obermannova R; Mortensen HR; Nordsmark M; Pfeiffer P; Elme A; Adenis A; Piessen G; Bruns CJ; Lordick F; Gockel I; Moehler M; Gani C; Liakakos T; Reynolds JV; Morganti AG; Rosati R; Castoro C; Cellini F; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; van Berge Henegouwen MI; Hulshoff MCCM; van Dieren J; Vollebergh M; van Sandick JW; Jeene P; Muijs C; Slingerland M; Voncken FEM; Hartgrink H; Creemers GJ; van der Sangen MJC; Nieuwenhuijzen GAP; Berbee M; Verheij M; Wijnhoven B; Beerepoot LV; Mohammad NH; Mook S; Ruurda JP; Kolodziejczyk P; Polkowski WP; Wyrwicz L; Alsina M; Tabernero J; Pera M; Kanonnikoff TF; Cervantes A; Nilsson M; Monig S; Wagner AD; Guckenberger M; Griffiths EA; Smyth E; Hanna GB; Markar S; Chaudry MA; Hawkins MA; Cheong E; van Laarhoven HWM; van Hillegersberg R;
Eur J Cancer; 2024 Jun; 204():114062. PubMed ID: 38678762
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic Breast Cancer: How to Manage It?
Barberi V; Pietragalla A; Franceschini G; Marazzi F; Paris I; Cognetti F; Masetti R; Scambia G; Fabi A
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207648
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcomes of patients with oligometastatic oesophagogastric cancer.
Down B; Lakunina S; Maynard N; Markar SR; Gordon-Weeks A
Eur J Surg Oncol; 2024 Apr; 50(4):108231. PubMed ID: 38461569
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative radiation therapy for brain metastasis in a pregnant patient: a case report.
Aninditha KP; Baumbach S; Ellethy T; Klumpp G; Golle A; Kuhn S; Wegner N; Ganslandt O; Münter MW
Strahlenther Onkol; 2024 May; ():. PubMed ID: 38748213
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer.
Verma V; Chang JY
J Thorac Dis; 2018 Jan; 10(1):21-24. PubMed ID: 29600013
[No Abstract] [Full Text] [Related]
10. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
[TBL] [Abstract][Full Text] [Related]
11. Evolution of treatment strategies for oligometastatic NSCLC patients - A systematic review of the literature.
Schanne DH; Heitmann J; Guckenberger M; Andratschke NHJ
Cancer Treat Rev; 2019 Nov; 80():101892. PubMed ID: 31522079
[TBL] [Abstract][Full Text] [Related]
12. Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
Dingemans AC; Hendriks LEL; Berghmans T; Levy A; Hasan B; Faivre-Finn C; Giaj-Levra M; Giaj-Levra N; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Smit EF; Van Schil P; Postmus PE; Ramella S; Lievens Y; Gaga M; Peled N; Scagliotti GV; Senan S; Paz-Ares L; Guckenberger M; McDonald F; Ekman S; Cufer T; Gietema H; Infante M; Dziadziuszko R; Peters S; Porta RR; Vansteenkiste J; Dooms C; de Ruysscher D; Besse B; Novello S
J Thorac Oncol; 2019 Dec; 14(12):2109-2119. PubMed ID: 31398540
[TBL] [Abstract][Full Text] [Related]
13. Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
Park S; Choe J; Lee SM; Choi S; Kim MJ; Chae EJ; Seo JB
Ann Surg Oncol; 2024 May; 31(5):3448-3458. PubMed ID: 38386197
[TBL] [Abstract][Full Text] [Related]
14. Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis.
Rim CH; Cho WK; Park S; Yoon WS; Yang DS
Int J Surg; 2023 Apr; 109(4):1006-1014. PubMed ID: 36974686
[TBL] [Abstract][Full Text] [Related]
15. Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis.
Li AY; Gaebe K; Zulfiqar A; Lee G; Jerzak KJ; Sahgal A; Habbous S; Erickson AW; Das S
JAMA Netw Open; 2023 Feb; 6(2):e230475. PubMed ID: 36821113
[TBL] [Abstract][Full Text] [Related]
16. Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis.
Rim CH; Cho WK; Lee JH; Kim YS; Suh YG; Kim KH; Chie EK; Ahn YC;
Cancer Res Treat; 2022 Oct; 54(4):953-969. PubMed ID: 35989655
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection.
Wasilewski D; Radke J; Xu R; Raspe M; Trelinska-Finger A; Rosenstock T; Poeser P; Schumann E; Lindner J; Heppner F; Kaul D; Suttorp N; Vajkoczy P; Frost N; Onken J
JAMA Netw Open; 2022 Apr; 5(4):e229553. PubMed ID: 35486401
[TBL] [Abstract][Full Text] [Related]
18. Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer.
Werner RS; Opitz I
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944994
[TBL] [Abstract][Full Text] [Related]
19. Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review.
Mentink JF; Paats MS; Dumoulin DW; Cornelissen R; Elbers JBW; Maat APWM; von der Thüsen JH; Dingemans AC
Transl Lung Cancer Res; 2021 Jul; 10(7):3329-3338. PubMed ID: 34430370
[TBL] [Abstract][Full Text] [Related]
20. Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review.
Rim CH; Shin IS; Park S; Lee HY
NPJ Precis Oncol; 2021 Jan; 5(1):2. PubMed ID: 33479481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
